Hello Colleagues,
The College on the Problems of Drug Dependence (CPDD) has composed an array of late-breaking talks - ranging from xylazine exposure to ED-delivered buprenorphine to international efforts in tobacco intervention. These talks are open access and available for you NOW at the following link: https://www.youtube.com/watch?v=qg2kLFYpscc The list of talks and speakers is provided for you below.
This is a sample of the digital programming that has been made available by CPDD this year- more information about registering and digital program offerings is available here: https://cpdd.org/meetings/current-meeting/cpdd-digital-experience/
- 0:00 Recent Xylazine Exposure Among Opioid Overdose Decedents, Renee Johnson, PhD, Johns Hopkins Bloomberg School of Public Health
- 5:25 Risks and Benefits of Obtaining a Medical Marijuana Card in Adults With Pain, Insomnia, or Affective Symptoms: A Randomized Clinical Trial, Jodi Gilman, PhD, Massachusetts General Hospital-Psychiatry
- 13:54: Trust in Provider Mediates the Relationship Between Shared Decision Making and Opioid Misuse in a Nationally Representative Sample of U.S. Veterans Prescribed Long-Term Opioid Therapy for Chronic Pain, Vanessa Somohano, PhD, VA Portland Health Care System
- 18:44: Implementation of Emergency Department-Initiated Buprenorphine for Opioid Use Disorder, Gail D'Onofrio, MD, Yale University School of Medicine
- 26:06: Contingency Management for Smoking Cessation Among Smokers With Overweight or Obesity, Gloria García-Fernández, PhD, University of Oviedo, Spain
- 30:27 An Examination of the Relationship Between Adverse Childhood Experiences (ACEs) and Substance Use Disorders (SUDs) Utilizing an Intersectionality Framework, Delisa Brown, PhD, Medical University of South Carolina Dept of Psychiatry & Behavioral Sciences
- 35:51: Absence of Withdrawal Symptoms upon Discontinuation of Daily Kratom Use in Three Formulations in a Controlled Clinical Study, Marilyn Huestis, PhD, National Institute of Drug Abuse, National Institutes of Health
- 40:30: Methamphetamine-Related Overdoses Before and During the COVID-19 Pandemic, Andrew Mike, MS, University of Florida
- 45:30: Differences Between Legal and Illegal Cannabis Demand in Spanish Young Adults With Hazardous and Non-Hazardous Cannabis Use, Alba Gonzalez-Roz, PhD, Department of Psychology - University of Oviedo
- 51:46: "My Dad Brought Me to a Drug Joint": A Qualitative Study on Adolescents and Amphetamine; Factors of Initiation, Amirul Danial Azmi, MD, Universiti Kebangsaan Malaysia Medical Centre
- 56:06: Contingency Management for Cigarette Smoking Cessation in Young People With Borderline Personality Disorder Features, Gillinder Bedi, BA, BSc, The University of Melbourne
Warm regards,
Kelly Dunn
Chair, CPDD Program Committee
---
Kelly Dunn, Ph.D., M.B.A.
Kelly Dunn, Ph.D., M.B.A.
Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030
Schedule a zoom meeting with me directly: https://calendly.com/kelly_dunn
No comments:
Post a Comment